Related Experiment Video
Updated: Jan 21, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Monoamine oxidase A inhibition by toxic concentrations of metaxalone
Brett Cherrington1,2, Ulrich Englich3, Supa Niruntari1,2
1Upstate New York Poison Center, Syracuse, NY, USA.
Abstract:
Context: Serotonin toxicity is a reported complication associated with both therapeutic use and overdose of metaxalone while on therapeutic doses of serotonergic drugs such as serotonin reuptake inhibitors. Monoamine oxidase A (MAO-A) inhibition by metaxalone has been proposed as the etiology of this toxicity. Metaxalone concentrations reported with cases of serotonin toxicity range from 31 to 61 mcg/ml (140-276 µM). We investigated the effect of metaxalone on MAO-A activity using an in vitro model.Methods: Metaxalone at concentrations ranging from 1.56 to 400 µM were incubated with a proprietary MAO substrate and recombinant human MAO-A for 1 h. After that, an esterase and luciferase were added and luminescence measured. Clorgyline, a known MAO-A inhibitor, was used as a positive control. Luminescence was measured using a Biotek Synergy HT microplate reader.Results: Metaxalone demonstrated significant dose-related inhibition of MAO-A activity. Four-parameter logistic regression analysis demonstrated a strong dose-response relationship at increasing concentrations.Conclusions: Our in vitro model shows that at toxic concentrations similar to those reported in case reports metaxalone shows significant MAO-A inhibition. Clinicians should be aware of this mechanism and understand the potentially lethal interactions metaxalone can have when prescribed with other serotonergic drugs and consider this as a potential cause of serotonin toxicity, especially in overdose scenarios.
Insights
Metaxalone significantly inhibits monoamine oxidase A (MAO-A) activity in vitro at toxic concentrations. This finding suggests MAO-A inhibition as a potential cause of serotonin toxicity when metaxalone is combined with serotonergic drugs.
Area of Science:
- Pharmacology
- Neuroscience
- Toxicology
Background:
- Serotonin toxicity is a known complication of metaxalone, particularly when co-administered with serotonergic drugs like SSRIs.
- Metaxalone's potential inhibition of monoamine oxidase A (MAO-A) has been hypothesized as the underlying mechanism for this toxicity.
- Reported metaxalone concentrations in toxicity cases range from 140-276 µM.
Purpose of the Study:
- To investigate the in vitro effect of metaxalone on the activity of monoamine oxidase A (MAO-A).
- To determine if metaxalone exhibits dose-dependent inhibition of MAO-A activity.
Main Methods:
- Recombinant human MAO-A was incubated with varying concentrations of metaxalone (1.56–400 µM) for 1 hour.
- MAO-A activity was assessed by measuring luminescence after the addition of a substrate, esterase, and luciferase.
- Clorgyline, a known MAO-A inhibitor, served as the positive control.
Main Results:
- Metaxalone demonstrated significant, dose-related inhibition of MAO-A activity across the tested concentrations.
- Four-parameter logistic regression analysis confirmed a strong dose-response relationship between metaxalone concentration and MAO-A inhibition.
- The observed inhibition occurred at concentrations comparable to those reported in clinical cases of metaxalone-associated serotonin toxicity.
Conclusions:
- This in vitro study confirms that metaxalone significantly inhibits MAO-A activity at toxic concentrations.
- Clinicians should consider MAO-A inhibition by metaxalone as a potential cause of serotonin toxicity, especially in overdose or when combined with other serotonergic agents.
- Awareness of this pharmacodynamic interaction is crucial for managing patients on metaxalone and serotonergic medications.
Related Concept Videos
Feedback Inhibition
Concentration Cells
Consider the following voltaic cell:
Enzyme Inhibition
Solution Concentration and Dilution
Concentration and Rate Law
For example, in a generic reaction aA + bB ⟶ products, where a and b are stoichiometric coefficients, the rate law can be written as:
Stress Concentrations
The stress...

